Relationship-Based Intervention for Post-Partum Depression
Launched by INTERDISCIPLINARY CENTER HERZLIYA · Dec 9, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special therapy designed to help mothers who are experiencing Post-Partum Depression (PPD) during the first year after giving birth. The therapy focuses on improving the relationship between mothers and their babies, with the hope that both the mother's feelings of sadness and the bond they share will get better. Researchers believe that this treatment may also increase levels of a hormone called oxytocin, which is important for building connections and nurturing.
To participate in this study, mothers need to be diagnosed with PPD, either mild or severe, and must be between 3 to 8 months after giving birth to one baby. Unfortunately, mothers of twins, premature babies, or those with certain serious health issues for themselves or their babies cannot join. If eligible, participants can expect to engage in short-term therapy sessions that focus on improving their emotional well-being and their relationship with their child. This is an exciting opportunity to receive support and potentially feel better during a challenging time.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women diagnosed with Post-Partum depression, major or minor, according to the Diagnostic and Statistical Manual of Mental Disorders, 5th version (DSM-5)
- • 3-8 months after birth of one baby
- Exclusion Criteria:
- • Mothers of twins
- • Mothers of premature babies
- • Comorbidity of psychopathology, women who have severe personality disorder or other psychiatric diagnose, besides depression or anxiety
- • Women or babies who suffer from severe medical condition, such as developmental problems for the baby or disability.
About Interdisciplinary Center Herzliya
The Interdisciplinary Center Herzliya (IDC Herzliya) is a leading academic institution in Israel, renowned for its innovative research and education in various fields, including health sciences. As a clinical trial sponsor, IDC Herzliya is committed to advancing medical knowledge and improving patient outcomes through rigorous scientific investigation and interdisciplinary collaboration. The center leverages its diverse expertise to design and conduct high-quality clinical trials, ensuring adherence to ethical standards and regulatory requirements. With a focus on translating research findings into practical applications, IDC Herzliya plays a pivotal role in the development of novel therapies and interventions that address critical healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Herzliya, , Israel
Patients applied
Trial Officials
Moran Influs, Phd
Study Director
Interdisciplinary Center Herzliya, Israel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials